NAD+ homeostasis in human health and disease

Depletion of nicotinamide adenine dinucleotide (NAD(+)), a central redox cofactor and the substrate of key metabolic enzymes, is the causative factor of a number of inherited and acquired diseases in humans. Primary deficiencies of NAD(+) homeostasis are the result of impaired biosynthesis, while secondary deficiencies can arise due to other factors affecting NAD(+) homeostasis, such as increased NAD(+) consumption or dietary deficiency of its vitamin B3 precursors. NAD(+) depletion can manifest in a wide variety of pathological phenotypes, ranging from rare inherited defects, characterized by congenital malformations, retinal degeneration, and/or encephalopathy, to more common multifactorial, often age-related, diseases. Here, we discuss NAD(+) biochemistry and metabolism and provide an overview of the etiology and pathological consequences of alterations of the NAD(+) metabolism in humans. Finally, we discuss the state of the art of the potential therapeutic implications of NAD(+) repletion for boosting health as well as treating rare and common diseases, and the possibilities to achieve this by means of the different NAD(+)-enhancing agents.

Automated summary

Depletion of NAD(+) can lead to various pathological phenotypes, from rare inherited defects to more common age-related diseases. Therapeutic implications of NAD(+) repletion for boosting health and treating diseases are discussed, along with the potential use of NAD(+)-enhancing agents.